Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -236,876 | -210,054 | -163,742 | -32,849 | -6,213 |
| Depreciation Amortization | 1,510 | 981 | 986 | 26 | 565 |
| Income taxes - deferred | -302 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | N/A | 100 | 105 | 80 |
| Accounts payable and accrued liabilities | 627 | 3,815 | 2,048 | 99 | -347 |
| Other Working Capital | 282 | 3,607 | 468 | 121 | -793 |
| Other Operating Activity | 209,454 | 187,290 | 149,978 | 25,126 | 1,354 |
| Operating Cash Flow | $-25,305 | $-14,361 | $-10,162 | $-7,372 | $-5,354 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -171,165 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,241 | -1,286 | -152 | -38 | -235 |
| Net Acquisitions | -1,818 | -1,818 | -1,818 | -1,818 | 0 |
| Purchase Sale Intangibles | N/A | N/A | -483 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -483 | 0 | -64 |
| Investing Cash Flow | $-175,224 | $-3,104 | $-2,453 | $-1,856 | $-299 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 316,452 | 316,189 | 70,976 | N/A | 63,118 |
| Debt Repayment | -132 | -132 | -132 | -132 | -53 |
| Common Stock Issued | 8,226 | 8,183 | 7,902 | 110 | 1,342 |
| Common Stock Repurchased | -4,798 | -4,798 | -4,798 | N/A | N/A |
| Other Financing Activity | -2,415 | -2,415 | 0 | 0 | 0 |
| Financing Cash Flow | $317,333 | $317,027 | $73,948 | $-22 | $64,407 |
| Exchange Rate Effect | N/A | -50 | N/A | N/A | 0 |
| Beginning Cash Position | 59,104 | 59,104 | 59,104 | 59,104 | 350 |
| End Cash Position | 175,908 | 358,616 | 120,437 | 49,854 | 59,104 |
| Net Cash Flow | $116,804 | $299,512 | $61,333 | $-9,250 | $58,754 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,305 | -14,361 | -10,162 | -7,372 | -5,354 |
| Capital Expenditure | -2,241 | -1,286 | -152 | -38 | -235 |
| Free Cash Flow | -27,546 | -15,647 | -10,314 | -7,410 | -5,589 |